Genewiz Overview
- Founded
-
1999

- Status
-
Acquired/Merged
- Employees
-
501

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$443M
Genewiz General Information
Description
Provider of genomics and DNA sequencing services designed to offer superior data quality with unparalleled technical support. The company's genomics and DNA sequencing services includes gene synthesis, molecular biology, next generation sequencing, bioinformatics and GLP regulatory services making research more productive and cost efficient, enabling researchers around the world to advance their scientific discoveries faster than ever before.
Contact Information
Website
www.genewiz.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Other Healthcare Services
Parent Company
Primary Office
- 115 Corporate Boulevard
- South Plainfield, NJ 07080
- United States
+1 (908) 000-0000
Genewiz Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Merger/Acquisition | 15-Nov-2018 | $443M | 00000 | Completed | Generating Revenue | |
2. Later Stage VC | 11-Jan-2016 | Completed | Generating Revenue | |||
1. Early Stage VC | Completed | Startup |
Genewiz Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Provider of genomics and DNA sequencing services designed to offer superior data quality with unparalleled technical sup
Biotechnology
South Plainfield, NJ
501
As of 2015
0000
0000-00-00
000000&0
Genewiz Competitors (19)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
CJ Bioscience | Formerly VC-backed | Seoul, South Korea | 000 | 000.00 | 000000000 | 000.00 |
00000 | Formerly VC-backed | Woburn, MA | 0 | 0000 | 00000000 | 0000 |
00000000 00000000 | Accelerator/Incubator Backed | Ebersberg, Germany | 000 | 000000000000 | ||
0000000 0000000000 | Formerly VC-backed | Menlo Park, CA | 000 | 00000 | 00000000 | 00000 |
000000000 | Venture Capital-Backed | Framingham, MA | 000 | 0000 | 000000000 | 0000 |
Genewiz Patents
Genewiz Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20160090590-A1 | High throughput sequencing of end regions of long linear dnas | Active | 25-Sep-2014 | 00000000000 | |
US-9938522-B2 | High throughput sequencing of end regions of long linear dnas | Active | 25-Sep-2014 | 00000000000 | 0 |
US-9745611-B2 | Methods and kits for identifying microorganisms in a sample | Active | 06-May-2014 | 00000000 | 0 |
US-20150322492-A1 | Methods and kits for identifying microorganisms in a sample | Active | 06-May-2014 | C12Q1/689 | 0 |
Genewiz Executive Team (8)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Yi Ge | Global CIO and China GM | ||
Ginger Zhou | Vice President, Global Next Generation Sequencing | ||
Xi Qin | Vice President, Finance |
Genewiz Board Members (3)
Name | Representing | Role | Since |
---|---|---|---|
Steve Sun | Genewiz | Co-Founder & Executive Chairman | 000 0000 |
Genewiz Signals
Genewiz Former Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Ampersand Capital Partners | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
Kenson Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
OrbiMed | PE/Buyout | Minority | 000 0000 | 000000 0 | |
Prime Value Capital Management | Venture Capital | Minority | 000 0000 | 000000 0 |
Genewiz Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000 00000 | 21-Dec-2015 | 0000000000 | Biotechnology | 00000 000 |